Joseph Moskal is the founder of Naurex. Naurex has raised $162M in total funding. Latest round: Series C. Based in Evanston, Illinois, United States.
Joseph Moskal is a biotech entrepreneur who founded Naurex, a Northwestern University spin-off focused on developing fast-acting antidepressants. After Naurex's acquisition by Allergan in 2015, he became the Chief Scientific Officer of Aptinyx, a spin-out comprised of the former Naurex team. Moskal retired from Aptinyx in July 2019.
Full founder directory · Investor directory · Company funding database · Fundraising library